Search for other papers by Ayse Nurcan Cebeci in
Google Scholar
PubMed
Search for other papers by Vera Schempp in
Google Scholar
PubMed
Search for other papers by Katharina Förtsch in
Google Scholar
PubMed
Search for other papers by Bettina Gohlke in
Google Scholar
PubMed
Search for other papers by Michaela Marx in
Google Scholar
PubMed
Search for other papers by Helmuth-Guenther Dörr in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is the primary aetiology of hyperthyroidism in children and adolescents, with a prevalence of about 1 in 10,000 ( 1 ). Down syndrome (DS) is one of the most common chromosomal disorders, occurring in nearly 1
Search for other papers by Mette H Viuff in
Google Scholar
PubMed
Department of Endocrinology, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
. ( https://doi.org/10.1186/s13023-018-0976-2 ) 10 Viuff MH Stochholm K Uldbjerg N Nielsen BB Gravholt CH . Only a minority of sex chromosome abnormalities are detected by the Danish national prenatal screening program for Down syndrome . Human
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Lukas Ochsner Ridder in
Google Scholar
PubMed
Department of Clinical Genetics and Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Agnethe Berglund in
Google Scholar
PubMed
Search for other papers by Kirstine Stochholm in
Google Scholar
PubMed
Unit for Thrombosis Research, Hospital of South West Jutland and University of Southern Denmark, Esbjerg, Denmark
Search for other papers by Simon Chang in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Unit for Thrombosis Research, Hospital of South West Jutland and University of Southern Denmark, Esbjerg, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
. Regardless, the need for evidence-based treatment programs in KS is evident no matter the age of the individual. In the same context, it is noteworthy, that compared to Down syndrome, available information on the internet describes KS as a genetic and
Search for other papers by Hiren Patt in
Google Scholar
PubMed
Search for other papers by Katrin Koehler in
Google Scholar
PubMed
Search for other papers by Sailesh Lodha in
Google Scholar
PubMed
Search for other papers by Swati Jadhav in
Google Scholar
PubMed
Search for other papers by Chaitanya Yerawar in
Google Scholar
PubMed
Search for other papers by Angela Huebner in
Google Scholar
PubMed
Search for other papers by Kunal Thakkar in
Google Scholar
PubMed
Search for other papers by Sneha Arya in
Google Scholar
PubMed
Search for other papers by Sandhya Nair in
Google Scholar
PubMed
Search for other papers by Manjunath Goroshi in
Google Scholar
PubMed
Search for other papers by Hosahithlu Ganesh in
Google Scholar
PubMed
Search for other papers by Vijaya Sarathi in
Google Scholar
PubMed
Search for other papers by Anurag Lila in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini Shah in
Google Scholar
PubMed
in TAS include microcephaly, short stature, dysmorphic facies with long narrow face, long philtrum, down-turned mouth, thin upper lip, lack of eyelashes, poor wound healing, palmar and plantar hyperkeratosis, scoliosis, osteoporosis, long QT syndrome
Search for other papers by Katica Bajuk Studen in
Google Scholar
PubMed
Search for other papers by Marija Pfeifer in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is a common disorder in women of reproductive age, with a prevalence 5–16% under different diagnostic criteria and across several ethnic groups, with exact pathogenesis still unclear ( 1 , 2 , 3
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by M Guftar Shaikh in
Google Scholar
PubMed
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Search for other papers by Timothy G Barrett in
Google Scholar
PubMed
Search for other papers by Nicola Bridges in
Google Scholar
PubMed
Search for other papers by Robin Chung in
Google Scholar
PubMed
Centre for Endocrinology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK
Search for other papers by Evelien F Gevers in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
Search for other papers by Anthony P Goldstone in
Google Scholar
PubMed
Search for other papers by Anthony Holland in
Google Scholar
PubMed
Search for other papers by Shankar Kanumakala in
Google Scholar
PubMed
Search for other papers by Ruth Krone in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Makarios Children's Hospital, Nicosia, Cyprus
Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed
Sussex Community NHS Trust, Brighton, UK
Search for other papers by E Anne Livesey in
Google Scholar
PubMed
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by Angela K Lucas-Herald in
Google Scholar
PubMed
Search for other papers by Christina Meade in
Google Scholar
PubMed
Search for other papers by Susan Passmore in
Google Scholar
PubMed
The University of Dublin, Trinity College Dublin, Dublin, Republic of Ireland
Search for other papers by Edna Roche in
Google Scholar
PubMed
Search for other papers by Chris Smith in
Google Scholar
PubMed
Search for other papers by Sarita Soni in
Google Scholar
PubMed
Journal of Medical Genetics. Part A 2007 143A 449 – 459 . ( https://doi.org/10.1002/ajmg.a.31507 ) 202 Cimolin V Galli M Grugni G Vismara L Albertini G Rigoldi C & Capodaglio P . Gait patterns in Prader-Willi and Down syndrome patients
Search for other papers by Caroline Culen in
Google Scholar
PubMed
Search for other papers by Diana-Alexandra Ertl in
Google Scholar
PubMed
Search for other papers by Katharina Schubert in
Google Scholar
PubMed
Search for other papers by Lisa Bartha-Doering in
Google Scholar
PubMed
Search for other papers by Gabriele Haeusler in
Google Scholar
PubMed
Introduction Turner syndrome (TS) is caused by structural anomalies in or complete loss of the X-chromosome (45X). Although a rare disease with an incidence of 1 in 2500 female births, it is nevertheless the most common sex chromosome
Willem-Alexander Children’s Hospital, Department of Pediatrics, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by H Vlaardingerbroek in
Google Scholar
PubMed
Search for other papers by E L T van den Akker in
Google Scholar
PubMed
Search for other papers by A C S Hokken-Koelega in
Google Scholar
PubMed
obesity: the Prader-Willi and the down syndromes . Metabolism: Clinical and Experimental 2007 56 1076 – 1080 . ( https://doi.org/10.1016/j.metabol.2007.03.016 ) 62 Bakker NE Siemensma EP Koopman C Hokken-Koelega AC Dietary energy intake
Search for other papers by Liza Haqq in
Google Scholar
PubMed
Search for other papers by James McFarlane in
Google Scholar
PubMed
Search for other papers by Gudrun Dieberg in
Google Scholar
PubMed
Search for other papers by Neil Smart in
Google Scholar
PubMed
Introduction Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine disorder, affecting 18–22% of reproductive-age women (1) . PCOS was first reported in 1935 by Stein & Leventhal (2) and is characterised by clinical or biochemical
The Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, UK
Search for other papers by M A Webb in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
Diabetes and Endocrinology Department, Kettering General Hospital NHS Foundation Trust, Kettering, UK
Search for other papers by H Mani in
Google Scholar
PubMed
Search for other papers by S J Robertson in
Google Scholar
PubMed
Search for other papers by H L Waller in
Google Scholar
PubMed
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK
Search for other papers by D R Webb in
Google Scholar
PubMed
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK
Search for other papers by C L Edwardson in
Google Scholar
PubMed
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK
Search for other papers by D H Bodicoat in
Google Scholar
PubMed
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK
Search for other papers by T Yates in
Google Scholar
PubMed
The Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, UK
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK
Search for other papers by K Khunti in
Google Scholar
PubMed
The Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, UK
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK
Search for other papers by M J Davies in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is the most common endocrine condition in women of reproductive age with a reported prevalence of up to 18% ( 1 ). Symptoms of PCOS include excess hair, irregular/absent periods and infertility